Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk - Wikidata - wikimedia - TriplyDB

Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk

Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk

http://www.wikidata.org/entity/Q28646415

about

Non communicable diseases and infections refuse to go away despite current knowledge and scientific advances.The effect of EGB on proliferation of gastric carcinoma SGC7901 cells.

P2860

Q35665217-CB3192A8-463E-4AF1-ACB8-EB6B9CF9C63B Q52908107-88F04974-BC1E-4453-90C9-8F67722B685A

P2860

Effect of Ginkgo biloba extract on the expressions of Cox-2 and GST-Pi in rats with hepatocellular carcinoma risk

http://www.wikidata.org/entity/Q28646415

description

2014 nî lūn-bûn

@nan

2014 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2014 թվականի մարտին հրատարակված գիտական հոդված

@hy

2014年の論文

@ja

2014年論文

@yue

2014年論文

@zh-hant

2014年論文

@zh-hk

2014年論文

@zh-mo

2014年論文

@zh-tw

2014年论文

@wuu

name

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@ast

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@en

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@nl

type

label

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@ast

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@en

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@nl

prefLabel

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@ast

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@en

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@nl

P1433

Q28646415-A8B60C7B-D148-480C-90AD-9193E3697055

P1476

Q28646415-6BFDEB8C-B764-4C56-AF42-71182AA51248

P2093

Q28646415-2D512C42-670B-46E5-BD62-82865BCC75E9

Q28646415-3804711B-66B6-405B-B278-8368E4CFD0E9

Q28646415-60BC016B-47BF-4B6C-AF28-2A1AB1DB073E

Q28646415-87BEC863-E1C2-488C-974F-DD1D981559F5

Q28646415-8BD96BE8-D867-4788-A5DC-CD02E16D08C6

Q28646415-EF64218C-7AA6-4CC7-A338-07FB05029A8E

P2860

Q28646415-02A3B49C-514F-45F1-A2DB-7A72A5E05667

Q28646415-140B0FF5-B9CF-4C7C-B6A9-1488234AABDE

Q28646415-3D6A81CC-65DC-40E0-B4ED-D1FAAFD64496

Q28646415-3F5C5E60-F9AE-454C-8DDA-3BBF9E414C22

Q28646415-422D10E7-71C6-4A42-A534-54FDCCFD5588

Q28646415-48C8ED86-B9D2-4A35-AF64-D88FBA12BAB4

Q28646415-4F2AE150-09A3-4C11-B1E7-E91234BC8E8B

Q28646415-519B2CE7-BA9C-421F-9B34-2738A7EB5A25

Q28646415-5346BA33-89EE-409C-B752-36056A565BAE

Q28646415-59E75B2C-D9E9-4CA7-ACE6-AE834E88B7A6

P304

Q28646415-7D237E92-F8FE-49CE-943F-9A486438AEC2

P31

Q28646415-94603FE7-3234-413B-84CB-D409F68D1BF1

P356

Q28646415-68DE668A-0AF9-4687-B700-B8F5358884EB

P407

Q28646415-E472D09A-030F-41A2-841E-1FC3939CF530

P433

Q28646415-1DA119AE-8215-4F93-AC6E-45998E968041

P478

Q28646415-C175E07E-4CB7-46EB-B957-A659DBBF4444

P577

Q28646415-C2EA3230-0C39-4F23-9CC4-30EBC21E7D42

P5875

Q28646415-80FB0CF1-60D0-46F9-911F-986AC6F54309

P698

Q28646415-E8015BF3-DE40-48CF-9E17-DFE75B24A21A

P921

Q28646415-B06FA8A3-2711-4898-B6B2-9045388C52DF

P932

Q28646415-350A3FC2-78B0-4C6E-ADA0-038E513492D8

P356

P1433

African Health Sciences

P1476

Effect of Ginkgo biloba extrac ...... hepatocellular carcinoma risk

@en

P2093

Chao Ou

http://www.w3.org/2001/XMLSchema#string

Guo-Jian Li

http://www.w3.org/2001/XMLSchema#string

Hai-Ping Zheng

http://www.w3.org/2001/XMLSchema#string

Ji Cao

http://www.w3.org/2001/XMLSchema#string

Jian-Jia Su

http://www.w3.org/2001/XMLSchema#string

Le-Qun Li

http://www.w3.org/2001/XMLSchema#string

P2860

All-trans retinoic acid can regulate the expressions of gelatinases and apolipoprotein E in glomerulosclerosis rats

Suppression of lipopolysaccharide-induced expression of inflammatory indicators in RAW 264.7 macrophage cells by extract prepared from Ginkgo biloba cambial meristematic cells.

Decreased expression of GST pi is correlated with a poor prognosis in human esophageal squamous carcinoma

Overexpression of cyclooxygenase-2 in noncancerous liver tissue increases the postoperative recurrence of hepatocellular carcinoma in patients with hepatitis B virus-related cirrhosis.

Apricoxib, a novel inhibitor of COX-2, markedly improves standard therapy response in molecularly defined models of pancreatic cancer.

A meta-analysis of the relationship between glutathione S-transferases gene polymorphism and hepatocellular carcinoma in Asian population.

Expression of c-erbB-2 and glutathione S-transferase-pi in hepatocellular carcinoma and its adjacent tissue.

Wnt-pathway activation in two molecular classes of hepatocellular carcinoma and experimental modulation by sorafenib.

Hepatocyte growth factor upregulation promotes carcinogenesis and epithelial-mesenchymal transition in hepatocellular carcinoma via Akt and COX-2 pathways

Asian consensus workshop report: expert consensus guideline for the management of intermediate and advanced hepatocellular carcinoma in Asia.

P304

37-48

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.4314/AHS.V14I1.7

http://www.w3.org/2001/XMLSchema#string

P407

P433

1

http://www.w3.org/2001/XMLSchema#string

P478

14

http://www.w3.org/2001/XMLSchema#string

P577

2014-03-01T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

272456305

http://www.w3.org/2001/XMLSchema#string

P698

26060456

http://www.w3.org/2001/XMLSchema#string

P921

P932

4449074

http://www.w3.org/2001/XMLSchema#string